Multimodality Imaging of Uterine Cervical Malignancies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32551909.
- Also identified by DOI 10.2214/AJR.19.21941.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>OBJECTIVE.</b> In this article, we provide an updated review on the role of imaging in initial staging, treatment monitoring, and follow-up of cervical cancer with a focus on the role of MRI and FDG PET/CT. In addition, the 2018 International Federation of Gynecology and Obstetrics staging system and its implication on management of cervical cancer are explored. <b>CONCLUSION.</b> Imaging plays a major role in treatment planning and as a prognostic indicator in patients with cervical cancer. MRI and PET/CT have complementary roles: MRI is essential for the local staging of the primary tumor, and PET/CT is the most useful modality for detecting regional nodal and distant metastases.
Medical subject headings
- Fluorodeoxyglucose F18
- Magnetic Resonance Imaging
- Positron Emission Tomography Computed Tomography
- Radiopharmaceuticals
- Uterine Cervical Neoplasms